Unknown PHASE2 INTERVENTIONAL 2-arm NCT01361763

Safety Study of Dabigatran in CADASIL (SONICA)

Phase II, Randomized, Crossover, Single Blind, Safety Trial of DABIGATRAN Versus ASA for Preventing Ischaemic Brain Lesions in Patients Affected by CADASIL

Sponsor: S. Andrea Hospital

Conditions CADASIL

Interventions Antiplatelets Dabigatran

Updated 5 times since 2017 Last updated: Feb 10, 2014 Started: Jun 30, 2011 Primary completion: Jan 31, 2015 Completion: Feb 28, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates CADASIL and is currently ongoing. S. Andrea Hospital leads this study, which shows 5 recorded versions since 2011 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE2
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE2

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE2
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE2
Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE2

First recorded

Jun 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

S. Andrea Hospital

Data source: S. Andrea Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Rome, Italy